Biomarkers for Lung Cancer Testing
March 21, 2014
Optimal Lung Cancer Treatment Requires Biomarker Testing
Biomarkers for lung cancer testing and biomarker testing are the subject of this important medical segment. Join Drs Gary Palmer and Deborah Morosini of Foundation Medicine as they share insight on the importance of testing and multidisciplinary coordination in its implementation and success. You’ll learn how this has had personal impact, and how the diagnosis and treatment of lung cancer is rapidly evolving. Learn how physicians are prolonging and improving the lives of cancer victims. Visit www.LetsTestNow.com or www.BoehringerIngelheim.com
Don’t move! The Balancing Act is back with a new Behind the Mystery segment and an inside look at a Broadway sensation.
We're discussing Alport syndrome, a rare, genetic, and chronic kidney condition characterized by declining kidney function which can lead to end-stage kidney disease.
When it comes to facial and body rejuvenation, discover a patient-first, non-surgical approach at Jupiter Plastic Surgery Center.